We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Ischemic heart disease is the leading noninfectious cause of death in adults in the United States.
Acute coronary syndrome (ACS) refers to symptoms attributable to atherosclerotic disease of the epicardial coronary arteries, usually caused by a fixed atherosclerotic lesion of varying severity.
ACS is a spectrum of disease and can present as acute myocardial infarction (AMI) or unstable angina (UA). AMI is myocardial ischemia with necrosis and can occur with or without ST segment elevation. The latter is referred to as non-ST-segment elevation myocardial infarction (NSTEMI). UA is reversible myocardial ischemia without necrosis.
This chapter discusses the diagnosis, evaluation and management of acute coronary syndrome (ACS). ACS is a spectrum of disease and can present as acute myocardial infarction (AMI) or unstable angina (UA). There are four main elements in the diagnosis of ACS: clinical history, physical examination, electrocardiogram findings and cardiac biomarkers. Any patient with ST-segment elevation myocardial infarction (STEMI) should undergo reperfusion with percutaneous coronary intervention (PCI) within 90 minutes of presentation. Fibrinolytics should be used for patients unable to undergo PCI within the recommended timeframe. Beta-antagonists have been shown to benefit post-MI patients within 24 hours of the initial event when administered orally. ACE inhibitors are also recommended within 24 hours post event, but not in the immediate treatment of ACS. The three most common reasons for decompensation of the ACS patient include cardiac arrhythmias, cardiogenic shock with congestive heart failure, and mechanical complications.